Search - tctmd.com

Displaying 1 - 20 of 51

Sort: Relevancy | Date

Presentation TCT 2025

Commentary

Presenter: Michael J. Reardon

October 27, 2025

Presentation TCT 2025

Trans-Apical Intrepid TMVR System: Long Term (5-Year) Technical and Clinical Results

Presenter: Michael J. Reardon

October 27, 2025

Presentation TCT 2025

PRO – TAVR: 3 Reasons why TAVR is the Best Option for this Patient

Presenter: Michael J. Reardon

October 26, 2025

Presentation TCT 2025

ARS 25: Imaging in SHD Interventions

Presenter: Michael J. Reardon

October 25, 2025

Presentation TCT 2024

A Closer Look at the ACURATE IDE Study

Presenter: NULL

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

Benefits of MR Elimination & "Why TMVR"

Presenter: Michael Reardon

October 29, 2024

Presentation TCT 2023

The Intrepid Journey to Date

Presenter: Michael Reardon

October 25, 2023

Presentation TCT 2023

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

Presenter: Michael Reardon

October 25, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

Presentation TCT 2023

China Experiences with J-Valve TAVR for Both Aortic Regurgitation and Stenosis

Presenter: Michael Reardon

October 23, 2023

Presentation TCT 2022

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Presenter: Michael Reardon

September 19, 2022

Presentation TCT 2022

Portico with FlexNav Introduction & Current Data

Presenter: Michael Reardon

September 17, 2022

Presentation TCT 2021

DurAVR THV: A Novel 3D Single Piece Valve Designed for Improved Durability and Hemodynamics

Presenter: Samir Kapadia

November 05, 2021

Presentation TCT 2018

Intrepid: Device Attributes, Implant Procedure, Clinical Results, and APOLLO Design and Status

Presenter: Michael J. Mack, David W.M. Muller, Michael J. Reardon

September 24, 2018

Presentation TCT 2018

Secondary Mitral Regurgitation With Severely Reduced LVEF

Presenter: Vinayak Bapat, Susheel K. Kodali, Philippe Genereux, Martin B. Leon, Scott Lim, Michael J. Mack, Raj Makkar, Patrick T. O'Gara, Michael J. Reardon, Allan Schwartz

September 23, 2018

Presentation TCT 2018

Bicuspid Aortic Stenosis: How To Treat

Presenter: Vinayak Bapat, Susheel K. Kodali, Philippe Genereux, Martin B. Leon, Scott Lim, Michael J. Mack, Raj Makkar, Patrick T. O'Gara, Michael J. Reardon, Allan Schwartz

September 23, 2018

Presentation TCT 2018

Low Surgical Risk Aortic Stenosis In The Us: The Patient Really Wants TAVR

Presenter: Vinayak Bapat, Susheel K. Kodali, Philippe Genereux, Martin B. Leon, Scott Lim, Michael J. Mack, Raj Makkar, Patrick T. O'Gara, Michael J. Reardon, Allan Schwartz

September 23, 2018

Presentation TCT 2018

Program Update: The LOTUS TAVR System

Presenter: Michael J. Reardon

September 22, 2018

Presentation TCT 2018

My Crystal Ball - Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Once the Cycle of Low-Risk Studies is Completed

Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon

September 22, 2018

Advertisement

Commentary

Trans-Apical Intrepid TMVR System: Long Term (5-Year) Technical and Clinical Results

PRO – TAVR: 3 Reasons why TAVR is the Best Option for this Patient

ARS 25: Imaging in SHD Interventions

A Closer Look at the ACURATE IDE Study

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Benefits of MR Elimination & "Why TMVR"

The Intrepid Journey to Date

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

Four-Year Outcomes From the EVOLUT Low Risk Trial

China Experiences with J-Valve TAVR for Both Aortic Regurgitation and Stenosis

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Portico with FlexNav Introduction & Current Data

DurAVR THV: A Novel 3D Single Piece Valve Designed for Improved Durability and Hemodynamics

Intrepid: Device Attributes, Implant Procedure, Clinical Results, and APOLLO Design and Status

Secondary Mitral Regurgitation With Severely Reduced LVEF

Bicuspid Aortic Stenosis: How To Treat

Low Surgical Risk Aortic Stenosis In The Us: The Patient Really Wants TAVR

Program Update: The LOTUS TAVR System

My Crystal Ball - Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Once the Cycle of Low-Risk Studies is Completed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content